Skip to content
Round-UpReport

JSPR

Jasper Therapeutics, Inc.

1-for-30 reverse split, effective Nov 6, 2026.

Ratio
1-for-30
Effective date
Nov 6, 2026
Split-adjusted trading
Same as the effective date, or not stated separately
Last day to buy
Nov 5, 2026

Shown only when the effective date is also when split-adjusted trading begins. Prior NYSE session. Calculated, not a filing field.

Be on record by
Filing does not state a record date
Fractional shares
Cash in lieu
Form
8-K

Filed Nov 4, 2026

Jasper's transfer agent, Continental Stock Transfer & Trust Company, will provide information to stockholders regarding their stock ownership following the Reverse Split and cash in lieu of fractional share payments, if applicable.

From the filing, on fractional shares.

Read the SEC filing

Broker reports

No approved reports yet. If your broker handled this split, send a report.

New round-up filings and broker reports. Unsubscribe any time.